DE3773442D1 - Dosierungsform zur verabreichung eines medikaments mit mitteln zur regelung der loeslichkeit. - Google Patents

Dosierungsform zur verabreichung eines medikaments mit mitteln zur regelung der loeslichkeit.

Info

Publication number
DE3773442D1
DE3773442D1 DE8787304209T DE3773442T DE3773442D1 DE 3773442 D1 DE3773442 D1 DE 3773442D1 DE 8787304209 T DE8787304209 T DE 8787304209T DE 3773442 T DE3773442 T DE 3773442T DE 3773442 D1 DE3773442 D1 DE 3773442D1
Authority
DE
Germany
Prior art keywords
administrating
solubility
controlling
dosage form
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787304209T
Other languages
English (en)
Inventor
Atul Devdatt Ayer
Patrick S-L Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DE3773442D1 publication Critical patent/DE3773442D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
DE8787304209T 1986-06-16 1987-05-12 Dosierungsform zur verabreichung eines medikaments mit mitteln zur regelung der loeslichkeit. Expired - Fee Related DE3773442D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,961 US4755180A (en) 1986-06-16 1986-06-16 Dosage form comprising solubility regulating member

Publications (1)

Publication Number Publication Date
DE3773442D1 true DE3773442D1 (de) 1991-11-07

Family

ID=25364968

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787304209T Expired - Fee Related DE3773442D1 (de) 1986-06-16 1987-05-12 Dosierungsform zur verabreichung eines medikaments mit mitteln zur regelung der loeslichkeit.

Country Status (6)

Country Link
US (1) US4755180A (de)
EP (1) EP0254394B1 (de)
JP (1) JPH085777B2 (de)
CA (1) CA1283829C (de)
DE (1) DE3773442D1 (de)
ES (1) ES2024508B3 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4871542A (en) * 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
US4994273A (en) * 1987-11-02 1991-02-19 Merck & Co., Inc. Solubility modulated drug delivery device
US4898734A (en) * 1988-02-29 1990-02-06 Massachusetts Institute Of Technology Polymer composite for controlled release or membrane formation
CA2001395C (en) * 1988-10-26 1995-10-03 Roy H. Hammerstedt Noningestible separation barrier with plugged pores
US5261870A (en) * 1988-10-26 1993-11-16 Biopore, Inc. Separation barrier with plugged pores
US5376383A (en) * 1988-11-21 1994-12-27 Merck & Co., Inc. Method for enhancing the lowering of plasma-cholesterol levels
US4997658A (en) * 1988-11-21 1991-03-05 Merck & Co., Inc. Method for enhancing the lowering of plasma cholesterol levels
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
TW235239B (de) * 1992-11-20 1994-12-01 Pfizer
GB9626233D0 (en) * 1996-12-18 1997-02-05 Chawla Brinda P S Medicament packaging and deliveery device
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
EP1239839A2 (de) 1999-12-23 2002-09-18 Pfizer Products Inc. Durch hydrogel gesteuerte mehrschichtige dosierungsform enthaltend sertralin
JP2005525299A (ja) * 2001-09-14 2005-08-25 スコラー インコーポレイテッド アミノ酸調節性の長期放出投薬形態
US20070098784A1 (en) * 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
JP5041651B2 (ja) * 2001-09-28 2012-10-03 ティーエヌティーギャンブル・インコーポレーテッド 生物体成分の送達系
GB0130055D0 (en) 2001-12-14 2002-02-06 Technology Innovation Ltd Medicament packaging
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
EP1603810B1 (de) 2003-03-15 2010-08-11 Brin Tech International Limited Verpackung für Arzneimittel
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
US20050053669A1 (en) * 2003-09-05 2005-03-10 Boehringer Ingelheim International Gmbh Administration form for the oral application of poorly soluble acidic and amphorteric drugs
US20050175701A1 (en) * 2004-02-10 2005-08-11 Alza Corporation Capillary moderator for osmotic delivery system
US20060045891A1 (en) * 2004-08-24 2006-03-02 Lovalenti Phillip M Density-matched suspension vehicles and pharmaceutical suspensions
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
CA2651855C (en) 2006-05-30 2011-08-02 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
ES2422864T3 (es) 2006-08-09 2013-09-16 Intarcia Therapeutics, Inc Sistemas de liberación osmótica y unidades de pistón
PT2157967E (pt) 2007-04-23 2013-04-03 Intarcia Therapeutics Inc Formulações de suspensões de péptidos insulinotrópicos e suas utilizações
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
KR101823699B1 (ko) 2009-09-28 2018-01-30 인타르시아 세라퓨틱스 인코포레이티드 실질 항정상태 약물 전달의 신속 확립 및/또는 종결
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
USD741471S1 (en) * 2013-10-01 2015-10-20 John F. LaGratta Cylindrical tablet having separable mating components
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815902A (en) * 1927-07-16 1931-07-28 Nat Aniline & Chem Co Inc Device for administering medicaments
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4236525A (en) * 1978-11-22 1980-12-02 Intermedics, Inc. Multiple function lead assembly
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4326525A (en) * 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
WO1983003061A1 (en) * 1982-03-04 1983-09-15 Battelle Development Corp Dual microcapsules
FR2524311A1 (fr) * 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
US4610686A (en) * 1983-11-02 1986-09-09 Alza Corporation Controlled delivery of haloperidol by an osmotic delivery system

Also Published As

Publication number Publication date
CA1283829C (en) 1991-05-07
US4755180A (en) 1988-07-05
EP0254394A1 (de) 1988-01-27
EP0254394B1 (de) 1991-10-02
JPS62298522A (ja) 1987-12-25
ES2024508B3 (es) 1992-03-01
JPH085777B2 (ja) 1996-01-24

Similar Documents

Publication Publication Date Title
DE3773442D1 (de) Dosierungsform zur verabreichung eines medikaments mit mitteln zur regelung der loeslichkeit.
DE3771112D1 (de) Vorrichtung zur stroemungskonstanten abgabe fluessiger arzneimittel.
ATE71837T1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
FI98196B (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
DE3874393D1 (de) Kuegelchen zur gesteuerten freisetzung eines arzneistoffs.
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
IT8222228A0 (it) Dispositivo per l'infusione di un medicamento.
DE3585899D1 (de) Apparat zum warnen eines patienten fuer den zeitpunkt der einnahme von medikamenten.
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
DK362189D0 (da) Farmaceutisk praeparat til intravenoes indgift
FI901787A0 (fi) Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi
IS3957A (is) Aðferð til framleiðslu á þrýstingsúðasamsetningumtil inntöku lyfja með innöndun
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
ES514214A0 (es) Un preparado farmaceutico.
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
DE3879111D1 (de) Pharmazeutische kautablette mit geschmaksmaskierung.
DE3787177D1 (de) Adapter zur Verbindung mit einer Ampulle zur Verabreichung eines Heilmittels.
FR2356642B1 (fr) La 2-bromo-6-fluoro-n-2-imidazolinylidene-benzamine, ses sels d'addition avec des acides, procedes pour leur preparation et les medicaments les renfermant
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
ZA884878B (en) Substituted benzimidazoles,a process for the preparation thereof,pharmaceutical formulations containing them,and the use thereof
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
PT87186A (pt) Imidazothiadiazine derivatives a process for preparing the same and their use as medicaments
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee